FDA
label_change
· 2017-07-21
FDA Approved: ZESTORETIC — Supplemental Application (Almatica Pharma Inc.)
Summary
The FDA approved a supplemental application for ZESTORETIC (lisinopril and hydrochlorothiazide) by Almatica Pharma Inc., resulting in updated labeling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ZESTORETIC (LISINOPRIL AND HYDROCHLOROTHIAZIDE)